pharma · Fatty Liver · Inflammatory Disease · GLMD
Galmed Pharmaceuticals
Galmed Pharmaceuticals clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 16 Ze’ev Tiomkin Street, Tel Aviv, 6578317, IL, USA
- Founded
- 2000
- Employees
- 10
- Programs
- 13
- Drugs
- 5
- Patents
- 11
Galmed Pharmaceuticals projects
7 ClinicalTrials.gov programs sponsored by Galmed Pharmaceuticals.
Galmed Pharmaceuticals has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
A study to compare two different aramchol formulations in healthy volunteers.
Galmed Pharmaceuticals
Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Primary sclerosing cholangitis
1 trial -
Aramchol
Galmed Pharmaceuticals
Healthy
4 trials -
Aramchol
Galmed Pharmaceuticals
Healthy Volunteers
2 trials -
Aramchol
Galmed Pharmaceuticals
NASH
1 trial -
Aramchol free acid tablet 600mg, single dose
Galmed Pharmaceuticals
Hepatic Impairment
1 trial -
Aramchol meglumine
Galmed Pharmaceuticals
Healthy
1 trial -
amilo-5MER
Galmed Pharmaceuticals
Inflammatory Disease
1 trial
Frequently asked questions
How many clinical projects does Galmed Pharmaceuticals have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.